Effects of combined ACE inhibitor and angiotensin II antagonist treatment in human chronic nephropathies
- 1 March 2003
- journal article
- clinical trial
- Published by Elsevier in Kidney International
- Vol. 63 (3) , 1094-1103
- https://doi.org/10.1046/j.1523-1755.2003.00832.x
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Proteinuria as a modifiable risk factor for the progression of non-diabetic renal diseaseKidney International, 2001
- Add-on angiotensin receptor blockade with maximized ACE inhibitionKidney International, 2001
- Renoprotective benefits of RAS inhibition: From ACEI to angiotensin II antagonistsKidney International, 2000
- Pathophysiology of Progressive NephropathiesNew England Journal of Medicine, 1998
- Is the antiproteinuric effect of ACE inhibition mediated by intereference in the renin-angiotensin system?Kidney International, 1994
- The Effect of Angiotensin-Converting-Enzyme Inhibition on Diabetic NephropathyNew England Journal of Medicine, 1993
- Effects of angiotensin II receptor blockade on remnant glomerular permselectivityKidney International, 1993
- Angiotensin II receptor blockade limits glomerular injury in rats with reduced renal mass.Journal of Clinical Investigation, 1992
- Angiotensin converting enzyme inhibition improves glomerular size-selectivity in IgA nephropathyKidney International, 1991
- Kinin contribution to renal vasodilator effect of captopril in rabbit.Hypertension, 1991